Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.

McMahan, Zsuzsanna; Schönhoff, Florian; Van Eyk, Jennifer E; Wigley, Fredrick M; Hummers, Laura K (2015). Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study. Arthritis research & therapy, 17, p. 201. BioMed Central 10.1186/s13075-015-0712-4

[img]
Preview
Text
s13075-015-0712-4.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (556kB) | Preview

INTRODUCTION

Significant pulmonary vascular disease is a leading cause of death in patients with scleroderma, and early detection and early medical intervention are important, as they may delay disease progression and improve survival and quality of life. Although several biomarkers have been proposed, there remains a need to define a reliable biomarker of early pulmonary vascular disease and subsequent development of pulmonary hypertension (PH). The purpose of this study was to define potential biomarkers for clinically significant pulmonary vascular disease in patients with scleroderma.

METHODS

The circulating growth factors basic fibroblast growth factor, placental growth factor (PlGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor, and soluble VEGF receptor 1 (sFlt-1), as well as cytokines (interleukin [IL]-1β IL-2, IL-4, IL-5, IL-8, IL-10, IL-12, IL-13, tumor necrosis factor-α, and interferon-γ), were quantified in patients with scleroderma with PH (n = 37) or without PH (n = 40). In non-parametric unadjusted analyses, we examined associations of growth factor and cytokine levels with PH. In a subset of each group, a second set of earlier samples, drawn 3.0±1.6 years earlier, were assessed to determine the changes over time.

RESULTS

sFlt-1 (p = 0.02) and PlGF (p = 0.02) were higher in the PH than in the non-PH group. sFlt-1 (ρ = 0.3245; p = 0.01) positively correlated with right ventricular systolic pressure. Both PlGF (p = 0.03) and sFlt-1 (p = 0.04) positively correlated with the ratio of forced vital capacity to diffusing capacity for carbon monoxide (DLCO), and both inversely correlated with DLCO (p = 0.01). Both PlGF and sFlt-1 levels were stable over time in the control population.

CONCLUSIONS

Our study demonstrated clear associations between regulators of angiogenesis (sFlt-1 and PlGF) and measures of PH in scleroderma and that these growth factors are potential biomarkers for PH in patients with scleroderma. Larger longitudinal studies are required for validation of our results.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiovascular Surgery

UniBE Contributor:

Schönhoff, Florian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1478-6354

Publisher:

BioMed Central

Language:

English

Submitter:

Daniela Huber

Date Deposited:

02 Feb 2016 15:09

Last Modified:

02 Feb 2016 15:09

Publisher DOI:

10.1186/s13075-015-0712-4

PubMed ID:

26245195

BORIS DOI:

10.7892/boris.74965

URI:

https://boris.unibe.ch/id/eprint/74965

Actions (login required)

Edit item Edit item
Provide Feedback